In 2011, Gupta and colleagues examined the effect of COX-2 inhibitors (valdecoxib or NS-398) on a MPTP-induced animal model of PD and reported the protective role of COX-2 inhibitors through a reduction in caspase-3 and NFκB activity (26). The gene discussed is CASP3; the disease is Parkinson disease.